Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 126,034 | 50,513 | 345,155 | 278,158 | 266,343 |
| Receivables | 313,018 | 375,631 | 202,339 | 223,488 | 238,739 |
| Inventories | 157,092 | 157,650 | 147,801 | 131,253 | 136,868 |
| Other current assets | 0 | 0 | 0 | 112 | 0 |
| TOTAL | $596,144 | $583,794 | $759,880 | $633,012 | $641,949 |
| Non-Current Assets | |||||
| PPE Net | 51,728 | 58,805 | 15,688 | 15,093 | 15,593 |
| Investments And Advances | 47,382 | 26,402 | 6,381 | 25,379 | 22,292 |
| Intangibles | 2,502,766 | 2,600,944 | 1,169,264 | 1,145,056 | 720,720 |
| Other Non-Current Assets | 0 | 0 | 26,569 | -1 | 0 |
| TOTAL | $2,601,876 | $2,686,151 | $1,217,902 | $1,185,527 | $758,604 |
| Total Assets | $3,198,020 | $3,270,054 | $1,977,781 | $1,818,539 | $1,400,322 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 112 | 231 |
| Accounts payable and accrued liabilities | 44,414 | 81,061 | 56,051 | 0 | 0 |
| Accrued Expenses | N/A | N/A | 185,345 | N/A | N/A |
| Other current liabilities | 743,484 | 739,480 | 513,266 | 732,066 | 320,859 |
| TOTAL | $796,802 | $829,487 | $800,068 | $732,290 | $321,090 |
| Non-Current Liabilities | |||||
| Long Term Debt | 592,752 | 656,237 | N/A | 447 | 578 |
| Other Non-Current Liabilities | 221,434 | 204,453 | 60,792 | 135,613 | 171,980 |
| TOTAL | $814,186 | $860,690 | $137,198 | $136,061 | $172,557 |
| Total Liabilities | $1,610,988 | $1,690,177 | $937,266 | $868,351 | $493,532 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 17,262 | N/A | N/A |
| Retained earnings | N/A | N/A | 456,392 | N/A | N/A |
| Other shareholders' equity | 1,587,032 | 1,579,877 | -16,609 | 950,188 | 906,791 |
| TOTAL | $1,587,032 | $1,579,877 | $1,040,515 | $950,188 | $906,791 |
| Total Liabilities And Equity | $3,198,020 | $3,270,054 | $1,977,781 | $1,818,539 | $1,400,322 |